DRAZAY Trademark

Trademark Overview

On Tuesday, August 26, 2014, a trademark application was filed for DRAZAY with the United States Patent and Trademark Office. The USPTO has given the DRAZAY trademark a serial number of 86376847. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 1, 2024. This trademark is owned by Glaxo Group Limited. The DRAZAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

General Information

Serial Number86376847
Word MarkDRAZAY
Filing DateTuesday, August 26, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 1, 2024
Registration Number5445738
Registration DateTuesday, April 17, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, September 8, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 29, 2014NEW APPLICATION ENTERED
Saturday, November 29, 2014ASSIGNED TO EXAMINER
Thursday, December 4, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 31, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 20, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, January 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 29, 2015SOU EXTENSION 1 FILED
Wednesday, July 29, 2015SOU EXTENSION 1 GRANTED
Friday, July 31, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2016SOU TEAS EXTENSION RECEIVED
Thursday, February 11, 2016SOU EXTENSION 2 FILED
Monday, March 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 14, 2016SOU EXTENSION 2 GRANTED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Monday, September 12, 2016SOU EXTENSION 3 FILED
Wednesday, September 14, 2016SOU EXTENSION 3 GRANTED
Thursday, September 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 16, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, March 16, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 11, 2018ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, April 25, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, April 28, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 21, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, March 8, 2018ASSIGNED TO PETITION STAFF
Tuesday, March 13, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, April 17, 2018REGISTERED-PRINCIPAL REGISTER
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 17, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 1, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

drazay pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological